Parapneumonic effusion and empyema: best therapeutic approach.
Bouros
D
D
Depts of Pneumonology and Clinical Pharmacology, Medical School, University of Crete, and University General Hospital, Heraklion, Crete, Greece. bouros@med.uoc.gr
Plataki
M
M
Antoniou
K M
KM
D015505:Chest Tubes; D003131:Combined Modality Therapy; D016724:Empyema, Pleural / Q000401:mortality / Q000628:therapy*; D006801:Humans; D010996:Pleural Effusion / Q000401:mortality / Q000628:therapy*; D018410:Pneumonia, Bacterial / Q000401:mortality / Q000628:therapy*; D017410:Practice Guidelines as Topic; D013300:Streptokinase / Q000008:administration & dosage; D015996:Survival Rate; D013907:Thoracostomy; D013908:Thoracotomy; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator